Health, Wellness & Beauty

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced strong third-quarter 2024 results, exceeding its previously issued earnings guidance. The company also provided an update on the ongoing recovery efforts at its North Cove, North Carolina manufacturing facility following the impact of Hurricane Helene.

Financial Performance

Baxter reported third-quarter 2024 sales of $3.85 billion, with sales from continuing operations increasing 4% on both a reported and constant currency basis. Adjusted diluted earnings per share (EPS) were $0.80, exceeding the company's guidance.

"Baxter delivered positive performance in the third quarter of 2024, as the company continues to execute against its strategic transformation," said José (Joe) E. Almeida, chair, president and chief executive officer.

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – Baxter International Inc., a global leader in healthcare, has provided an update on the recovery efforts at its North Cove, North Carolina manufacturing site following the impact of Hurricane Helene. The company is focused on supporting its employees, restoring operations, and ensuring ongoing product supply to patients.

Employee and Community Support

Baxter is committed to supporting its employees and the affected communities in North Carolina. All employees at the North Cove facility have been accounted for, and the company has provided various forms of assistance, including:

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – A kidney disease diagnosis can be overwhelming, raising many questions and uncertainties for patients and their families. However, there is hope. By understanding their condition and treatment options, patients can feel empowered to make informed decisions and live fulfilling lives.

This article shares inspiring stories of individuals around the world who are navigating their kidney care journeys with resilience and hope.

Mr. Yu: Hiking Enthusiast from Hong Kong

Mr. Yu, an avid hiker who has conquered numerous mountains in Hong Kong and beyond, faced a daunting challenge when diagnosed with kidney disease. Requiring dialysis, he worried about the impact on his active lifestyle.

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – The prevalence of chronic diseases is increasing, particularly in the U.S., leading to a greater need for long-term care. This trend, coupled with evolving care models and labor shortages, is driving a shift towards more care being delivered in the comfort of patients' homes.

Baxter, a global leader in healthcare, is at the forefront of this transformation, providing innovative tools and connected devices that empower patients to effectively manage chronic conditions like hypertension, respiratory illnesses, and cardiac issues at home.

Connected Care: Meeting Patients Where They Are

Baxter's connected care solutions leverage technology to make care more convenient and collaborative, supporting patient safety and well-being.

Hypertension Management

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – Two-year-old Nicklaus is a typical toddler by day, full of energy and curiosity. But by night, he transforms into a kidney care superhero, bravely battling a chronic condition he's faced since birth.

Born prematurely with only 5% kidney function, Nicklaus's journey has been filled with challenges. A blockage in his urethra and an enlarged bladder led to a 72-day stay in the neonatal intensive care unit (NICU).

A Devastating Diagnosis and a Family's Strength

"His diagnosis was devastating. It was very hard on our family," says his mother, Kayla. "We went through a lot, and we came out stronger."

Despite the initial shock and uncertainty, Nicklaus's family has found strength and resilience in navigating his kidney care journey.

Peritoneal Dialysis: Enabling a Normal Childhood

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – Baxter, a leading name in the medtech industry, is taking bold steps to transform its supply chain, ensuring that life-saving products reach patients quickly and reliably. In the wake of the COVID-19 pandemic, which exposed vulnerabilities in global supply chains across all sectors, Baxter is investing heavily in innovation to build a more resilient and efficient system.

SHERIDAN, WYOMING – November 10, 2024 – Christopher Nelson, a service specialist at Baxter, has been inducted into the National Private Truck Council (NPTC) Driver Hall of Fame. Nelson, who is based in Earth City, Mo., has been with Baxter for 35 years and has a spotless safety record. He is one of only four drivers in the United States to receive this prestigious honor.

"Chris demonstrates daily what it truly means to Save and Sustain Lives," said Daniel Gentry, Baxter regional operations manager. "He has established valuable relationships with nurses, clinics and industry experts, and has amassed a wealth of knowledge that he gladly shares with colleagues and patients alike."

The NPTC Driver Hall of Fame recognizes drivers who have demonstrated a commitment to safety and service excellence throughout their careers. Nelson has logged more than one million miles without incident – the equivalent of driving two round trips to the moon!

SHERIDAN, WYOMING – November 10, 2024 – Akron Bio, a recognized leader in biomanufacturing, continues to expand its capabilities in the field of recombinant protein development and manufacturing. With decades of experience and an unwavering commitment to quality, Akron offers comprehensive services designed to meet the needs of clients across the biotechnology, pharmaceutical, and gene therapy industries. By combining cutting-edge technology, cGMP compliance, and a deep understanding of recombinant protein production, Akron is poised to deliver innovative solutions for complex biomanufacturing challenges.

SHERIDAN, WYOMING – November 10, 2024 – Akron Bio, a leader in biotechnology and biomanufacturing, has continued to elevate its commitment to quality and innovation with the introduction of its state-of-the-art cGMP (current Good Manufacturing Practice) facility. Located in Sheridan, Wyoming, this new facility is poised to meet the ever-growing demand for high-quality plasmid DNA production, a critical component in the development of gene therapies, vaccines, and other advanced biologics.
Akron Bio’s new facility has been meticulously designed to meet the highest regulatory standards, ensuring that every stage of its plasmid DNA production is held to the strictest quality and compliance measures. This advanced facility operates in full compliance with FDA 21 CFR Part 11 and Eudralex Vol. 4 Annex 11, ensuring that both ancillary materials and drug substances are manufactured to the highest cGMP standards.

SHERIDAN, WYOMING – November 10, 2024 – PSI Engineering, a leading provider of end-to-end pack line solutions, has announced its successful collaboration with Cardinal Health at-Home Solutions to revolutionize their outbound operations through advanced automation technology. This partnership has significantly enhanced Cardinal Health at-Home Solutions' distribution centers, enabling them to meet the growing demand for at-home medical supplies with greater efficiency and speed.
Cardinal Health at-Home Solutions, a division of Cardinal Health, plays a crucial role in providing essential medical supplies and equipment directly to approximately 5 million patients across the United States annually. These patients rely on Cardinal Health at-Home Solutions for critical products to manage chronic and serious medical conditions such as diabetes, incontinence, and more.